Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.18	13.48	23.37	18.52	29.69	8.76
Cash & Short-Term Investments	13.18	13.48	23.37	18.52	29.69	8.76
Cash Growth	137.16%	-42.33%	26.17%	-37.62%	238.89%	4538999.48%
Prepaid Expenses	0.33	1.21	0.33	0.4	1.72	0
Total Current Assets	13.51	14.68	23.7	18.92	31.4	8.76
Other Long-Term Assets	0.82	0.82	-	-	-	-
Total Assets	14.33	15.5	23.7	18.92	31.4	8.76
Accounts Payable	5.43	6.28	3.85	3.52	0.51	1.01
Accrued Expenses	3.68	7.36	12.93	6.14	1.84	0.32
Short-Term Debt	-	0.46	-	-	-	-
Other Current Liabilities	0.63	0.5	0.4	0.3	-	-
Total Current Liabilities	9.74	14.6	17.18	9.96	2.34	1.33
Other Long-Term Liabilities	0.04	0.09	0.81	0.57	0.37	1.96
Total Liabilities	9.78	14.69	17.98	10.53	2.72	3.3
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	185.31	165.08	140.07	103.49	95.52	63.77
Retained Earnings	-180.77	-164.27	-134.35	-95.09	-66.83	-58.31
Total Common Equity	4.55	0.81	5.72	8.39	28.69	5.47
Shareholders' Equity	4.55	0.81	5.72	8.39	28.69	5.47
Total Liabilities & Equity	14.33	15.5	23.7	18.92	31.4	8.76
Total Debt	-	0.46	-	-	-	-
Net Cash (Debt)	13.18	13.02	23.37	18.52	29.69	8.76
Net Cash Growth	140.75%	-44.29%	26.17%	-37.62%	238.89%	-
Net Cash Per Share	0.25	0.39	0.98	0.95	2.01	2.86
Filing Date Shares Outstanding	115.06	46.74	27.92	20.45	15.13	9.23
Total Common Shares Outstanding	96.34	46.58	27.92	20.45	14.43	9.23
Working Capital	3.77	0.08	6.53	8.96	29.06	7.43
Book Value Per Share	0.05	0.02	0.20	0.41	1.99	0.59
Tangible Book Value	4.55	0.81	5.72	8.39	28.69	5.47
Tangible Book Value Per Share	0.05	0.02	0.20	0.41	1.99	0.59

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q